1. Главная
  2. Ресурсы
  3. Библиотечный поиск
First-in-human, phaseI dose-escalationstudy of single andmultiple doses of afirst-in-classenhancer offluoropyrimidines, adUTPase inhibitor(TAS-114)… Kaku SaitoHirotaka NagashimaKeiichi Noguchi2014 год

First-in-human, phase I dose-escalation study of single and multiple doses of a first-in-class enhancer of fluoropyrimidines, a dUTPase inhibitor (TAS-114) in healthy male volunteers
статья из журнала

Страница публикацииПубликация в OpenAlex
Год издания: 2014
Авторы: Kaku Saito, Hirotaka Nagashima, Keiichi Noguchi, Kunihiro Yoshisue, Tatsushi Yokogawa, Eiji Matsushima, Takeshi Tahara, Takagi Shigeru
Издательство: Springer Science+Business Media
Источник: Cancer Chemotherapy and Pharmacology
Ключевые слова: PARP inhibition in cancer therapy, DNA Repair Mechanisms, Colorectal Cancer Treatments and Studies
Другие ссылки: Cancer Chemotherapy and Pharmacology (HTML)
PubMed (HTML)